Qbrelis

Active Ingredient(s): Lisinopril
FDA Approved: * July 29, 2016
Pharm Company: * SILVERGATE PHARMS
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Qbrelis Overview

Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class used primarily in treatment of high blood pressure, heart failure, and after heart attacks. It is also used for preventing kidney and eye complications in people with diabetes. Its indications, contraindications, and side effects are as those for all ACE inhibitors. Lisinopril was the third ACE inhibitor (after captopril and enalapril) and was introduced into therapy in the early 1990s.[3] A number of properties d...

Read more Qbrelis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lisinopril

Recent Qbrelis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lisinopril
  • Solution: 1mg/ml
  • Tablet: 10mg, 2.5mg, 20mg, 30mg, 40mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Qbrelis: (1 result)

Sorted by National Drug Code
  • 52652-3001 Qbrelis 1 mg/ml Oral Solution by Silvergate Pharmaceuticals, Inc.

Other drugs which contain Lisinopril or a similar ingredient: (6 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 27 May 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.